USFDA successfully completes inspection at Alkem Laboratories’ Taloja facility

12 Aug 2016 Evaluate

Alkem Laboratories has been issued ‘no 483s’ by the United States Food and Drug Administration (USFDA) for it Taloja facility. The USFDA has inspected the company’s Bioequivalence Facility at Taloja in state of Maharashtra from August 01 to August 10, 2016. At the end of the inspection, there were no 483s issued by the USFDA.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.



Alkem Laboratories Share Price

5450.00 141.15 (2.66%)
23-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1494.95
Dr. Reddys Lab 5882.45
Cipla 1487.45
Zydus Lifesciences 1087.65
Lupin 1631.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.